Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 17/20 | 0.72 |
| ▸ | SULT1A1 | P50225 | 4/20 | 0.67 |
| ▸ | MAPT | P10636 | 2/20 | 0.67 |
| ▸ | TP53 | P04637 | 1/20 | 0.53 |
| ▸ | THRB | P10828 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10032146 | 1.00 | APP (0.72) | APPSULT1A1MAPTTP53THRB | |
| SCHEMBL10032131 | 0.92 | APP (0.73) | APPSULT1A1MAPTTP53THRB | |
| SCHEMBL10311767 | 0.92 | APP (0.73) | APPSULT1A1MAPTTP53THRB | |
| SCHEMBL10032132 | 0.91 | APP (0.69) | APPSULT1A1MAPTTP53THRB | |
| SCHEMBL16256416 | 0.89 | APP (0.66) | APPSULT1A1MAPTTP53THRB | |
| SCHEMBL13045481 | 0.88 | APP (0.70) | APPSULT1A1MAPTTP53THRB | |
| SCHEMBL16256417 | 0.88 | APP (0.61) | APPSULT1A1MAPTTP53THRB | |
| SCHEMBL24133691 | 0.87 | APP (0.60) | APPSULT1A1MAPTTP53THRB | |
| SCHEMBL10311787 | 0.86 | APP (0.63) | APPSULT1A1MAPTTP53THRB | |
| SCHEMBL13904152 | 0.86 | APP (0.67) | APPSULT1A1MAPTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260062607-A1 | TWO-DIMENSIONAL LATTICE CONFINED SINGLE-MOLECULE-LIKE AGGREGATES | PURDUE RESEARCH FOUNDATION (US) | 2026-03-05 | — | — | US | claimed |
| EP-4652549-A1 | APPARATUS FOR A TILED LEARNING PROCESSING ELEMENT AND ARCHITECTURE | Mignon Technologies Ltd (GB) | 2025-11-26 | — | — | EP | claimed |
| CN-110892267-B | System and method for real-time glycan determination of a sample | 安进公司 | 2024-08-09 | — | — | CN | claimed |
| WO-2024153922-A1 | APPARATUS FOR A TILED LEARNING PROCESSING ELEMENT AND ARCHITECTURE | UNIVERSITY OF NEWCASTLE UPON TYNE (GB) | 2024-07-25 | — | — | WO | claimed |
| WO-2026099341-A1 | BIOCONTAINMENT OF UNWANTED ENGINEERED CELLS USING NON-NATURAL AMINO ACIDS | SNIPR BIOME APS (DK) | 2026-05-15 | — | — | WO | disclosed |
| CN-122036906-A | Recombinant protein of novel cytokine for promoting collagen regeneration, and preparation method and application thereof | 四川大学华西口腔医院 | 2026-05-15 | — | — | CN | disclosed |
| EP-4739777-A1 | TRANSMISSIBLE ELEMENTS COMPRISING PATHWAY MODIFICATION SYSTEMS AND EXOGENOUS NUCLEIC ACIDS FOR THE PRODUCTION OF MOLECULES OF INTEREST | SNIPR Biome ApS (DK) | 2026-05-13 | — | — | EP | disclosed |
| US-12612395-B2 | Rocaglate derivatives and uses thereof | TRUSTEES OF BOSTON UNIVERSITY (US) | 2026-04-28 | — | — | US | disclosed |
| US-20260109991-A1 | PHAGE-DERIVED PARTICLES FOR IN SITU DELIVERY OF DNA PAYLOAD INTO C. ACNES POPULATION | ELIGO BIOSCIENCE (FR) | 2026-04-23 | — | — | US | disclosed |
| US-12577275-B2 | Hydrophobic interaction chromatography carrier and protein purification method | JNC CORPORATION (JP) | 2026-03-17 | — | — | US | disclosed |
| US-20260062607-A1 | TWO-DIMENSIONAL LATTICE CONFINED SINGLE-MOLECULE-LIKE AGGREGATES | PURDUE RESEARCH FOUNDATION (US) | 2026-03-05 | — | — | US | disclosed |
| EP-4677075-A2 | TARGETING CELLS IN STRESSED GROWING CONDITIONS | SNIPR Biome ApS (DK) | 2026-01-14 | — | — | EP | disclosed |
| WO-2022096590-A1 | PHAGE-DERIVED PARTICLES FOR IN SITU DELIVERY OF DNA PAYLOAD INTO C. ACNES POPULATION | ELIGO BIOSCIENCE (FR) | 2022-05-12 | — | — | WO | disclosed |
| WO-2022096596-A1 | CUTIBACTERIUM ACNES RECOMBINANT PHAGES, METHOD OF PRODUCTION AND USES THEREOF | ELIGO BIOSCIENCE (FR) | 2022-05-12 | — | — | WO | disclosed |
| US-20220135987-A1 | CUTIBACTERIUM ACNES RECOMBINANT PHAGES, METHOD OF PRODUCTION AND USES THEREOF | ELIGO BIOSCIENCE (FR) | 2022-05-05 | — | — | US | disclosed |
| US-20220135986-A1 | PHAGE-DERIVED PARTICLES FOR IN SITU DELIVERY OF DNA PAYLOAD INTO C. ACNES POPULATION | ELIGO BIOSCIENCE (FR) | 2022-05-05 | — | — | US | disclosed |
| CN-114372543-A | RFID (radio frequency identification device) indoor multi-target 3D (three-dimensional) positioning system and method based on carrier phase | 重庆邮电大学 | 2022-04-19 | — | — | CN | disclosed |
| US-11279708-B2 | Amidino- and amino-rocaglates as novel translation inhibitors and anticancer agents | TRUSTEES OF BOSTON UNIVERSITY (US) | 2022-03-22 | — | — | US | disclosed |
| US-11249026-B2 | Use of raman spectroscopy to monitor culture medium | BIOGEN MA INC. (US) | 2022-02-15 | — | — | US | disclosed |
| US-20220033830-A1 | FUNCTIONALIZATION OF ENDOGENOUS BACTERIA | TRUSTEES OF BOSTON UNIVERSITY (US) | 2022-02-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11279708-B2 | Amidino- and amino-rocaglates as novel translation inhibitors and anticancer agents | EIF2B3, EIF4EBP1, G3BP1 | APP 2369/4885SULT1A1 3929/4885MAPT 3972/4885 |
| US-20260062607-A1 | TWO-DIMENSIONAL LATTICE CONFINED SINGLE-MOLECULE-LIKE AGGREGATES | BLM, MEF2D, SNCA | APP 3405/4885SULT1A1 3552/4885MAPT 144/4885 |
| US-12612395-B2 | Rocaglate derivatives and uses thereof | GLRB, SRR, HCAR3 | APP 3988/4885SULT1A1 174/4885MAPT 4722/4885 |
| US-12577275-B2 | Hydrophobic interaction chromatography carrier and protein purification method | SSB, MAX, CD81 | APP 863/4885SULT1A1 4777/4885MAPT 2490/4885 |
| US-20260109991-A1 | PHAGE-DERIVED PARTICLES FOR IN SITU DELIVERY OF DNA PAYLOAD INTO C. ACNES POPULATION | CUTA, STAT3, POLL | APP 562/4885SULT1A1 3613/4885MAPT 2996/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.